MModal IP LLC. - Medical Equipment - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
MModal IP LLC. (MModal) is a healthcare technology provider of clinical transcription services and clinical documentation workflow solutions. The companys product portfolio comprises fluency direct, fluency mobile, M*modal scout, fluency for coding, fluency for imaging, fluency voice manager, fluency for practices, fluency for transcription and services, fluency flex, SpeechQ for radiology, catalyst for radiology and quality. It also provides services such as the M*Modal coding, scribing, adoption and medical transcription services. The company partners with hospitals, health systems and group medical practices among others, to offer its cloud-based, speech understanding technology. MModal is headquartered in Franklin, the US.
MModal IP LLC. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
MModal IP LLC. (MModal) is a healthcare technology provider of clinical transcription services and clinical documentation workflow solutions. The companys product portfolio comprises fluency direct, fluency mobile, M*modal scout, fluency for coding, fluency for imaging, fluency voice manager, fluency for practices, fluency for transcription and services, fluency flex, SpeechQ for radiology, catalyst for radiology and quality. It also provides services such as the M*Modal coding, scribing, adoption and medical transcription services. The company partners with hospitals, health systems and group medical practices among others, to offer its cloud-based, speech understanding technology. MModal is headquartered in Franklin, the US.
MModal IP LLC. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Proteome Sciences Plc, Medical Equipment, Deal Details 10
Partnerships 10
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Proteome Sciences Enters Into Collaboration With Buck Institute 13
Proteome Sciences Enters Into Co-Development Agreement With H. Lee Moffitt Cancer Center 14
Equity Offering 15
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 15
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 18
Proteome Sciences Plc - Key Competitors 19
Proteome Sciences Plc - Key Employees 20
Proteome Sciences Plc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 22
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 23
Sep 15, 2016: Proteome Sciences: Interim Results 34
May 18, 2016: Proteome Sciences: Preliminary Results for Year Ended 31st December, 2015 35
Corporate Communications 38
Aug 01, 2017: Proteome Sciences: Directorate changes 38
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 39
Jun 01, 2016: Proteome Sciences Announces CEO Appointment 40
May 18, 2016: Proteome Sciences: CEO Appointment 41
May 18, 2016: Proteome Sciences Announces Appointment of Nominated Adviser and Broker 42
Legal and Regulatory 43
Oct 18, 2017: Proteome Sciences: GCLP Accreditation and Trading Update 43
Jun 12, 2017: Proteome Sciences: New Registered Address 44
Product News 45
Sep 22, 2016: Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimers Biomarkers 45
Other Significant Developments 46
Jul 28, 2016: Proteome Sciences: Trading Updateand Notice of Results 46
Mar 09, 2016: Proteome Sciences: Trading update 47
Feb 29, 2016: Proteome Sciences: Trading Update 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List Of Tables
Proteome Sciences Plc, Medical Equipment, Key Facts, 2016 2
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Proteome Sciences Plc, Deals By Market, 2011 to YTD 2017 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Proteome Sciences Enters Into Collaboration With Buck Institute 13
Proteome Sciences Enters Into Co-Development Agreement With H. Lee Moffitt Cancer Center 14
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 15
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 18
Proteome Sciences Plc, Key Competitors 19
Proteome Sciences Plc, Key Employees 20
Proteome Sciences Plc, Subsidiaries 21
List Of Figures
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 2
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 2
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Proteome Sciences Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
RELATED REPORTS
MModal IP LLC - Strategic SWOT Analysis Review
MModal IP LLC - Strategic SWOT Analysis Review
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
